Sysmex starts marketing lectin which detects liver fibrosis early

The lectin was developed in a long-term NEDO project. Japan has about 3 million patients affected by viral hepatitis.

NEDO news release, December 26, 2013

Sysmex starts marketing lectin which detects liver fibrosis early
Scroll to top